Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

doi:10.1084/jem.183.1.317

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Paglia, P.
	Articles by Colombo, M. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Paglia, P.
	Articles by Colombo, M. P.


Social Bookmarking

	What's this?

ARTICLES

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

P Paglia, C Chiodoni, M Rodolfo and MP Colombo
Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.

The priming of an immune response against a major histocompatibility complex class I-restricted antigen expressed by nonhematopoietic cells involves the transfer of that antigen to a host bone marrow-derived antigen presenting cell (APC) for presentation to CD8+ T lymphocytes. Dendritic cells (DC), as bone marrow-derived APC, are first candidates for presentation of tumor-associated antigens (TAA). The aim of this study was to see whether DC are able to prime in vivo antigen-specific cytotoxic T lymphocytes after exposure to a soluble protein antigen in vitro. Lacking a well-defined murine TAA, we took advantage of beta- galactosidase (beta-gal)-transduced tumor cell lines as a model in which beta-gal operationally functions as TAA. For in vivo priming both a DC line, transduced or not transduced with the gene coding for murine GM-CSF, and fresh bone marrow-derived DC (bm-DC), loaded in vitro with soluble beta-gal, were used. Priming with either granulocyte macrophage colony-stimulating factor-transduced DC line or fresh bm-DC but not with untransduced DC line generated CTL able to lyse beta-gal- transfected target cells. Furthermore, GM-CSF was necessary for the DC line to efficiently present soluble beta-gal as an H-2Ld-restricted peptide to a beta-gal-specific CTL clone. Data also show that a long- lasting immunity against tumor challenge can be induced using beta-gal- pulsed bm-DC as vaccine. These results indicate that effector cells can be recruited and activated in vivo by antigen-pulsed DC, providing an efficient immune reaction against tumors.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Jeon, Y. H., Choi, Y., Yoon, S. O., Kim, C. W., Chung, J.-K. (2008). Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy. Molecular Cancer Therapeutics 7: 2252-2260 [Abstract] [Full Text]
Koido, S., Hara, E., Homma, S., Mitsunaga, M., Takahara, A., Nagasaki, E., Kawahara, H., Watanabe, M., Toyama, Y., Yanagisawa, S., Kobayashi, S., Yanaga, K., Fujise, K., Gong, J., Tajiri, H. (2007). Synergistic Induction of Antigen-Specific CTL by Fusions of TLR-Stimulated Dendritic Cells and Heat-Stressed Tumor Cells. J. Immunol. 179: 4874-4883 [Abstract] [Full Text]
Koido, S., Hara, E., Homma, S., Torii, A., Mitsunaga, M., Yanagisawa, S., Toyama, Y., Kawahara, H., Watanabe, M., Yoshida, S., Kobayashi, S., Yanaga, K., Fujise, K., Tajiri, H. (2007). Streptococcal Preparation OK-432 Promotes Fusion Efficiency and Enhances Induction of Antigen-Specific CTL by Fusions of Dendritic Cells and Colorectal Cancer Cells. J. Immunol. 178: 613-622 [Abstract] [Full Text]
Grolleau-Julius, A., Garg, M. R., Mo, R., Stoolman, L. L., Yung, R. L. (2006). Effect of Aging on Bone Marrow-Derived Murine CD11c+CD4-CD8{alpha}- Dendritic Cell Function.. J. Gerontol. A Biol. Sci. Med. Sci. 61: 1039-1047 [Abstract] [Full Text]
Maksimow, M., Miiluniemi, M., Marttila-Ichihara, F., Jalkanen, S., Hanninen, A. (2006). Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity. Blood 108: 1298-1305 [Abstract] [Full Text]
Mullins, D. W., Engelhard, V. H. (2006). Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.. J. Immunol. 176: 4535-4542 [Abstract] [Full Text]
Fushimi, T., O'Connor, T. P., Crystal, R. G. (2006). Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.. Cancer Res. 66: 3513-3522 [Abstract] [Full Text]
Batchu, R. B., Moreno, A. M., Szmania, S. M., Bennett, G., Spagnoli, G. C., Ponnazhagan, S., Barlogie, B., Tricot, G., van Rhee, F. (2005). Protein Transduction of Dendritic Cells for NY-ESO-1-Based Immunotherapy of Myeloma. Cancer Res. 65: 10041-10049 [Abstract] [Full Text]
Koido, S., Hara, E., Homma, S., Torii, A., Toyama, Y., Kawahara, H., Watanabe, M., Yanaga, K., Fujise, K., Tajiri, H., Gong, J., Toda, G. (2005). Dendritic Cells Fused with Allogeneic Colorectal Cancer Cell Line Present Multiple Colorectal Cancer-Specific Antigens and Induce Antitumor Immunity against Autologous Tumor Cells. Clin. Cancer Res. 11: 7891-7900 [Abstract] [Full Text]
Kammertoens, T., Willebrand, R., Erdmann, B., Li, L., Li, Y., Engels, B., Uckert, W., Blankenstein, T. (2005). CY15, a Malignant Histiocytic Tumor That Is Phenotypically Similar to Immature Dendritic Cells. Cancer Res. 65: 2560-2564 [Abstract] [Full Text]
Mazzolini, G., Alfaro, C., Sangro, B., Feijoo, E., Ruiz, J., Benito, A., Tirapu, I., Arina, A., Sola, J., Herraiz, M., Lucena, F., Olague, C., Subtil, J., Quiroga, J., Herrero, I., Sadaba, B., Bendandi, M., Qian, C., Prieto, J., Melero, I. (2005). Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas. JCO 23: 999-1010 [Abstract] [Full Text]
Avigan, D. (2004). Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma. Clin. Cancer Res. 10: 6347S-6352S [Abstract] [Full Text]
Avigan, D., Vasir, B., Gong, J., Borges, V., Wu, Z., Uhl, L., Atkins, M., Mier, J., McDermott, D., Smith, T., Giallambardo, N., Stone, C., Schadt, K., Dolgoff, J., Tetreault, J.-C., Villarroel, M., Kufe, D. (2004). Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses. Clin. Cancer Res. 10: 4699-4708 [Abstract] [Full Text]
Ullenhag, G. J., Frodin, J.-E., Jeddi-Tehrani, M., Strigard, K., Eriksson, E., Samanci, A., Choudhury, A., Nilsson, B., Rossmann, E. D., Mosolits, S., Mellstedt, H. (2004). Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. Clin. Cancer Res. 10: 3273-3281 [Abstract] [Full Text]
Mapara, M. Y., Sykes, M. (2004). Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance. JCO 22: 1136-1151 [Abstract] [Full Text]
Higano, C. S., Vogelzang, N. J., Sosman, J. A., Feng, A., Caron, D., Small, E. J (2004). Safety and Biological Activity of Repeated Doses of Recombinant Human Flt3 Ligand in Patients with Bone Scan-Negative Hormone-Refractory Prostate Cancer. Clin. Cancer Res. 10: 1219-1225 [Abstract] [Full Text]
van den Broeke, L. T., Daschbach, E., Thomas, E. K., Andringa, G., Berzofsky, J. A. (2003). Dendritic Cell-Induced Activation of Adaptive and Innate Antitumor Immunity. J. Immunol. 171: 5842-5852 [Abstract] [Full Text]
Chiriva-Internati, M., Liu, Y., Weidanz, J. A., Grizzi, F., You, H., Zhou, W., Bumm, K., Barlogie, B., Mehta, J. L., Hermonat, P. L. (2003). Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24. Blood 102: 3100-3107 [Abstract] [Full Text]
Tatsumi, T., Huang, J., Gooding, W. E., Gambotto, A., Robbins, P. D., Vujanovic, N. L., Alber, S. M., Watkins, S. C., Okada, H., Storkus, W. J. (2003). Intratumoral Delivery of Dendritic Cells Engineered to Secrete Both Interleukin (IL)-12 and IL-18 Effectively Treats Local and Distant Disease in Association with Broadly Reactive Tc1-type Immunity. Cancer Res. 63: 6378-6386 [Abstract] [Full Text]
Crittenden, M., Gough, M., Harrington, K., Olivier, K., Thompson, J., Vile, R. G. (2003). Expression of Inflammatory Chemokines Combined with Local Tumor Destruction Enhances Tumor Regression and Long-term Immunity. Cancer Res. 63: 5505-5512 [Abstract] [Full Text]
Tschoep, K., Manning, T. C., Harlin, H., George, C., Johnson, M., Gajewski, T. F. (2003). Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. J. Leukoc. Biol. 74: 69-80 [Abstract] [Full Text]
Muller, M. R., Grunebach, F., Nencioni, A., Brossart, P. (2003). Transfection of Dendritic Cells with RNA Induces CD4- and CD8-Mediated T Cell Immunity Against Breast Carcinomas and Reveals the Immunodominance of Presented T Cell Epitopes. J. Immunol. 170: 5892-5896 [Abstract] [Full Text]
Saha, A., Chatterjee, S. K., Foon, K. A., Primus, F. J., Bhattacharya-Chatterjee, M. (2003). Murine Dendritic Cells Pulsed with an Anti-Idiotype Antibody Induce Antigen-specific Protective Antitumor Immunity. Cancer Res. 63: 2844-2854 [Abstract] [Full Text]
Hamilton, S. E., Harty, J. T. (2002). Quantitation of CD8+ T Cell Expansion, Memory, and Protective Immunity After Immunization with Peptide-Coated Dendritic Cells. J. Immunol. 169: 4936-4944 [Abstract] [Full Text]
Luhrs, P., Schmidt, W., Kutil, R., Buschle, M., Wagner, S. N., Stingl, G., Schneeberger, A. (2002). Induction of Specific Immune Responses by Polycation-Based Vaccines. J. Immunol. 169: 5217-5226 [Abstract] [Full Text]
Gatza, E., Okada, C. Y. (2002). Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma. J. Immunol. 169: 5227-5235 [Abstract] [Full Text]
Tatsumi, T., Gambotto, A., Robbins, P. D., Storkus, W. J. (2002). Interleukin 18 Gene Transfer Expands the Repertoire of Antitumor Th1-type Immunity Elicited by Dendritic Cell-based Vaccines in Association with Enhanced Therapeutic Efficacy. Cancer Res. 62: 5853-5858 [Abstract] [Full Text]
Steller, M. A. (2002). Cervical Cancer Vaccines: Progress and Prospects. Reproductive Sciences 9: 254-264 [Abstract]
Vicari, A. P., Chiodoni, C., Vaure, C., Ait-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., O'Garra, A., Trinchieri, G., Caux, C. (2002). Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti-Interleukin 10 Receptor Antibody. J. Exp. Med. 196: 541-549 [Abstract] [Full Text]
Melero, I., Gabari, I., Corbi, A. L., Relloso, M., Mazzolini, G., Schmitz, V., Rodriguez-Calvillo, M., Tirapu, I., Camafeita, E., Albar, J. P., Prieto, J. (2002). An Anti-ICAM-2 (CD102) Monoclonal Antibody Induces Immune-mediated Regressions of Transplanted ICAM-2-negative Colon Carcinomas. Cancer Res. 62: 3167-3174 [Abstract] [Full Text]
Prabakaran, I., Menon, C., Xu, S., Gomez-Yafal, A., Czerniecki, B. J., Fraker, D. L. (2002). Mature CD83+ Dendritic Cells Infected With Recombinant gp100 Vaccinia Virus Stimulate Potent Antimelanoma T Cells. Ann. Surg. Oncol. 9: 411-418 [Abstract] [Full Text]
Olasz, E. B., Linton, J., Katz, S. I. (2002). Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. Int Immunol 14: 493-502 [Abstract] [Full Text]
von Bergwelt-Baildon, M. S., Vonderheide, R. H., Maecker, B., Hirano, N., Anderson, K. S., Butler, M. O., Xia, Z., Zeng, W. Y., Wucherpfennig, K. W., Nadler, L. M., Schultze, J. L. (2002). Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 99: 3319-3325 [Abstract] [Full Text]
Gong, J., Koido, S., Chen, D., Tanaka, Y., Huang, L., Avigan, D., Anderson, K., Ohno, T., Kufe, D. (2002). Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Blood 99: 2512-2517 [Abstract] [Full Text]
Bachleitner-Hofmann, T., Stift, A., Friedl, J., Pfragner, R., Radelbauer, K., Dubsky, P., Schuller, G., Benko, T., Niederle, B., Brostjan, C., Jakesz, R., Gnant, M. (2002). Stimulation of Autologous Antitumor T-Cell Responses Against Medullary Thyroid Carcinoma Using Tumor Lysate-Pulsed Dendritic Cells. J. Clin. Endocrinol. Metab. 87: 1098-1104 [Abstract] [Full Text]
Kemp, R. A., Ronchese, F. (2001). Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity. J. Immunol. 167: 6497-6502 [Abstract] [Full Text]
Tatsumi, T., Takehara, T., Kanto, T., Miyagi, T., Kuzushita, N., Sugimoto, Y., Jinushi, M., Kasahara, A., Sasaki, Y., Hori, M., Hayashi, N. (2001). Administration of Interleukin-12 Enhances the Therapeutic Efficacy of Dendritic Cell-based Tumor Vaccines in Mouse Hepatocellular Carcinoma. Cancer Res. 61: 7563-7567 [Abstract] [Full Text]
Wang, B., Norbury, C. C., Greenwood, R., Bennink, J. R., Yewdell, J. W., Frelinger, J. A. (2001). Multiple Paths for Activation of Naive CD8+ T Cells: CD4-Independent Help. J. Immunol. 167: 1283-1289 [Abstract] [Full Text]
Ju, D. W., Tao, Q., Lou, G., Bai, M., He, L., Yang, Y., Cao, X. (2001). Interleukin 18 Transfection Enhances Antitumor Immunity Induced by Dendritic Cell-Tumor Cell Conjugates. Cancer Res. 61: 3735-3740 [Abstract] [Full Text]
Liu, S., Yu, Y., Zhang, M., Wang, W., Cao, X. (2001). The Involvement of TNF-{{alpha}}-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-{{beta}}-Stimulated Human Dendritic Cells to Tumor Cells. J. Immunol. 166: 5407-5415 [Abstract] [Full Text]
Fong, L., Brockstedt, D., Benike, C., Wu, L., Engleman, E. G. (2001). Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients. J. Immunol. 166: 4254-4259 [Abstract] [Full Text]
Zoller, M., Christ, O. (2001). Prophylactic Tumor Vaccination: Comparison of Effector Mechanisms Initiated by Protein Versus DNA Vaccination. J. Immunol. 166: 3440-3450 [Abstract] [Full Text]
Wang, X.-Y., Kazim, L., Repasky, E. A., Subjeck, J. R. (2001). Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity. J. Immunol. 166: 490-497 [Abstract] [Full Text]
Stager, S., Smith, D. F., Kaye, P. M. (2000). Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral Leishmaniasis. J. Immunol. 165: 7064-7071 [Abstract] [Full Text]
Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H.-A., Krieg, A. M., Hartmann, G., Endres, S. (2000). Enhanced Dendritic Cell Maturation by TNF-{alpha} or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo. J. Immunol. 165: 6278-6286 [Abstract] [Full Text]
Koido, S., Kashiwaba, M., Chen, D., Gendler, S., Kufe, D., Gong, J. (2000). Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA. J. Immunol. 165: 5713-5719 [Abstract] [Full Text]
Rosic-Kablar, S., Chan, K., Reis, M. D., Dubé, I. D., Hough, M. R. (2000). Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice. Proc. Natl. Acad. Sci. USA 10.1073/pnas.240221297v1 [Abstract] [Full Text]
Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., Brugger, W. (2000). Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96: 3102-3108 [Abstract] [Full Text]
Cochlovius, B., Stassar, M., Christ, O., Raddrizzani, L., Hammer, J., Mytilineos, I., Zoller, M. (2000). In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program. J. Immunol. 165: 4731-4741 [Abstract] [Full Text]
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanovic, S., Ockert, D., Rammensee, H.-G., Rieber, E. P. (2000). Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides. Cancer Res. 60: 4845-4849 [Abstract] [Full Text]
Bellone, M., Cantarella, D., Castiglioni, P., Crosti, M. C., Ronchetti, A., Moro, M., Garancini, M. P., Casorati, G., Dellabona, P. (2000). Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma. J. Immunol. 165: 2651-2656 [Abstract] [Full Text]
Herr, W., Ranieri, E., Olson, W., Zarour, H., Gesualdo, L., Storkus, W. J. (2000). Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses. Blood 96: 1857-1864 [Abstract] [Full Text]
Vicari, A. P., Ait-Yahia, S., Chemin, K., Mueller, A., Zlotnik, A., Caux, C. (2000). Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms. J. Immunol. 165: 1992-2000 [Abstract] [Full Text]
Brossart, P., Zobywalski, A., Grünebach, F., Behnke, L., Stuhler, G., Reichardt, V. L., Kanz, L., Brugger, W. (2000). Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells. Cancer Res. 60: 4485-4492 [Abstract] [Full Text]
Lipford, G. B., Sparwasser, T., Zimmermann, S., Heeg, K., Wagner, H. (2000). CpG-DNA-Mediated Transient Lymphadenopathy Is Associated with a State of Th1 Predisposition to Antigen-Driven Responses. J. Immunol. 165: 1228-1235 [Abstract] [Full Text]
Hoffmann, T. K., Meidenbauer, N., Dworacki, G., Kanaya, H., Whiteside, T. L. (2000). Generation of Tumor-specific T Lymphocytes by Cross-Priming with Human Dendritic Cells Ingesting Apoptotic Tumor Cells. Cancer Res. 60: 3542-3549 [Abstract] [Full Text]
Davila, E., Celis, E. (2000). Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity. J. Immunol. 165: 539-547 [Abstract] [Full Text]
Kikuchi, T., Moore, M. A. S., Crystal, R. G. (2000). Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors. Blood 96: 91-99 [Abstract] [Full Text]
Mach, N., Gillessen, S., Wilson, S. B., Sheehan, C., Mihm, M., Dranoff, G. (2000). Differences in Dendritic Cells Stimulated in Vivo by Tumors Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor or Flt3-Ligand. Cancer Res. 60: 3239-3246 [Abstract] [Full Text]
Russo, V., Zhou, D., Sartirana, C., Rovere, P., Villa, A., Rossini, S., Traversari, C., Bordignon, C. (2000). Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood 95: 3473-3477 [Abstract] [Full Text]
Klein, C., Bueler, H., Mulligan, R. C. (2000). Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines. J. Exp. Med. 191: 1699-1708 [Abstract] [Full Text]
Robinson, C., Callow, M., Stevenson, S., Scott, B., Robinson, B. W. S., Lake, R. A. (2000). Serologic Responses in Patients with Malignant Mesothelioma . Evidence for Both Public and Private Specificities. Am. J. Respir. Cell Mol. Bio. 22: 550-556 [Abstract] [Full Text]
Forni, G., Lollini, P. L., Musiani, P., Colombo, M. P. (2000). Immunoprevention of Cancer: Is the Time Ripe?. Cancer Res. 60: 2571-2575 [Abstract] [Full Text]
Timmerman, J. M., Levy, R. (2000). Linkage of Foreign Carrier Protein to a Self-Tumor Antigen Enhances the Immunogenicity of a Pulsed Dendritic Cell Vaccine. J. Immunol. 164: 4797-4803 [Abstract] [Full Text]
Yang, S., Kittlesen, D., Slingluff, C. L. Jr., Vervaert, C. E., Seigler, H. F., Darrow, T. L. (2000). Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3. J. Immunol. 164: 4204-4211 [Abstract] [Full Text]
Roth, M. D., Gitlitz, B. J., Kiertscher, S. M., Park, A. N., Mendenhall, M., Moldawer, N., Figlin, R. A. (2000). Granulocyte Macrophage Colony-stimulating Factor and Interleukin 4 Enhance the Number and Antigen-presenting Activity of Circulating CD14+ and CD83+ Cells in Cancer Patients. Cancer Res. 60: 1934-1941 [Abstract] [Full Text]
Blanas, E., Davey, G. M., Carbone, F. R., Heath, W. R. (2000). A Bone Marrow-Derived APC in the Gut-Associated Lymphoid Tissue Captures Oral Antigens and Presents Them to Both CD4+ and CD8+ T Cells. J. Immunol. 164: 2890-2896 [Abstract] [Full Text]
Seo, N., Tokura, Y., Nishijima, T., Hashizume, H., Furukawa, F., Takigawa, M. (2000). Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc. Natl. Acad. Sci. USA 97: 371-376 [Abstract] [Full Text]
Fanger, N. A., Maliszewski, C. R., Schooley, K., Griffith, T. S. (1999). Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL). J. Exp. Med. 190: 1155-1164 [Abstract] [Full Text]
Ahuja, S. S., Reddick, R. L., Sato, N., Montalbo, E., Kostecki, V., Zhao, W., Dolan, M. J., Melby, P. C., Ahuja, S. K. (1999). Dendritic Cell (DC)-Based Anti-Infective Strategies: DCs Engineered to Secrete IL-12 Are a Potent Vaccine in a Murine Model of an Intracellular Infection. J. Immunol. 163: 3890-3897 [Abstract] [Full Text]
Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., Taniguchi, M. (1999). Cutting Edge: Inhibition of Experimental Tumor Metastasis by Dendritic Cells Pulsed with {alpha}-Galactosylceramide. J. Immunol. 163: 2387-2391 [Abstract] [Full Text]
Borges, L., Miller, R. E., Jones, J., Ariail, K., Whitmore, J., Fanslow, W., Lynch, D. H. (1999). Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo. J. Immunol. 163: 1289-1297 [Abstract] [Full Text]
Chiodoni, C., Paglia, P., Stoppacciaro, A., Rodolfo, M., Parenza, M., Colombo, M. P. (1999). Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-stimulating Factor (GM-CSF) and CD40 Ligand Genes Take Up and Present Endogenous Tumor-associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response. J. Exp. Med. 190: 125-134 [Abstract] [Full Text]
Curiel-Lewandrowski, C., Mahnke, K., Labeur, M., Roters, B., Schmidt, W., Granstein, R. D., Luger, T. A., Schwarz, T., Grabbe, S. (1999). Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity. J. Immunol. 163: 174-183 [Abstract] [Full Text]
Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., Brugger, W. (1999). Identification of HLA-A2-Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies. Blood 93: 4309-4317 [Abstract] [Full Text]
Morse, M. A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M.-E., Lyerly, H. K. (1999). A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen. Clin. Cancer Res. 5: 1331-1338 [Abstract] [Full Text]
Chakraborty, N. G., Li, L., Sporn, J. R., Kurtzman, S. H., Ergin, M. T., Mukherji, B. (1999). Emergence of Regulatory CD4+ T Cell Response to Repetitive Stimulation with Antigen-Presenting Cells In Vitro: Implications in Designing Antigen-Presenting Cell-Based Tumor Vaccines. J. Immunol. 162: 5576-5583 [Abstract] [Full Text]
Baar, J. (1999). Clinical Applications of Dendritic Cell Cancer Vaccines. The Oncologist 4: 140-144 [Full Text]
Shimizu, K., Fields, R. C., Giedlin, M., Mule, J. J. (1999). Systemic administration of interleukin 2�enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc. Natl. Acad. Sci. USA 96: 2268-2273 [Abstract] [Full Text]
Greten, T. F., Jaffee, E. M. (1999). Cancer Vaccines. JCO 17: 1047-1047 [Abstract] [Full Text]
Murakami, M., Gurski, K. J., Marincola, F. M., Ackland, J., Steller, M. A. (1999). Induction of Specific CD8+ T-Lymphocyte Responses Using a Human Papillomavirus-16 E6/E7 Fusion Protein and Autologous Dendritic Cells. Cancer Res. 59: 1184-1187 [Abstract] [Full Text]
Schultze, J. L., Michalak, S., Lowne, J., Wong, A., Gilleece, M. H., Gribben, J. G., Nadler, L. M. (1999). Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon gamma , and IL-10: Role of B Cells in the Maintenance of �T Cell Responses. J. Exp. Med. 189: 1-12 [Abstract] [Full Text]
Redchenko, I. V., Rickinson, A. B. (1999). Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells. J. Virol. 73: 334-342 [Abstract] [Full Text]
De Veerman, M., Heirman, C., Van Meirvenne, S., Devos, S., Corthals, J., Moser, M., Thielemans, K. (1999). Retrovirally Transduced Bone Marrow-Derived Dendritic Cells Require CD4+ T Cell Help to Elicit Protective and Therapeutic Antitumor Immunity. J. Immunol. 162: 144-151 [Abstract] [Full Text]
Labeur, M. S., Roters, B., Pers, B., Mehling, A., Luger, T. A., Schwarz, T., Grabbe, S. (1999). Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage. J. Immunol. 162: 168-175 [Abstract] [Full Text]
Brossart, P., Grunebach, F., Stuhler, G., Reichardt, V. L., Mohle, R., Kanz, L., Brugger, W. (1998). Generation of Functional Human Dendritic Cells From Adherent Peripheral Blood Monocytes by CD40 Ligation in the Absence of Granulocyte-Macrophage Colony-Stimulating Factor. Blood 92: 4238-4247 [Abstract] [Full Text]
Wang, J., Saffold, S., Cao, X., Krauss, J., Chen, W. (1998). Eliciting T Cell Immunity Against Poorly Immunogenic Tumors by Immunization with Dendritic Cell-Tumor Fusion Vaccines. J. Immunol. 161: 5516-5524 [Abstract] [Full Text]
Shimizu, Y., Guidotti, L. G., Fowler, P., Chisari, F. V. (1998). Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice. J. Immunol. 161: 4520-4529 [Abstract] [Full Text]
Paglia, P., Medina, E., Arioli, I., Guzman, C. A., Colombo, M. P. (1998). Gene Transfer in Dendritic Cells, Induced by Oral DNA Vaccination With Salmonella typhimurium, Results in Protective Immunity Against a Murine Fibrosarcoma. Blood 92: 3172-3176 [Abstract] [Full Text]
Bourguin, I., Moser, M., Buzoni-Gatel, D., Tielemans, F., Bout, D., Urbain, J., Leo, O. (1998). Murine Dendritic Cells Pulsed In Vitro with Toxoplasma gondii Antigens Induce Protective Immunity In Vivo. Infect. Immun. 66: 4867-4874 [Abstract] [Full Text]
Guillaume, T., Rubinstein, D. B., Symann, M. (1998). Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation. Blood 92: 1471-1490 [Full Text]
Ahuja, S. S., Mummidi, S., Malech, H. L., Ahuja, S. K. (1998). Human Dendritic Cell (DC)-Based Anti-Infective Therapy: Engineering DCs to Secrete Functional IFN-{gamma} and IL-12. J. Immunol. 161: 868-876 [Abstract] [Full Text]
Bohm, W., Thoma, S., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (1998). T Cell-Mediated, IFN-{gamma}-Facilitated Rejection of Murine B16 Melanomas. J. Immunol. 161: 897-908 [Abstract] [Full Text]
Fioretti, F., Fradelizi, D., Stoppacciaro, A., Ramponi, S., Ruco, L., Minty, A., Sozzani, S., Garlanda, C., Vecchi, A., Mantovani, A. (1998). Reduced Tumorigenicity and Augmented Leukocyte Infiltration After Monocyte Chemotactic Protein-3 (MCP-3) Gene Transfer: Perivascular Accumulation of Dendritic Cells in Peritumoral Tissue and Neutrophil Recruitment Within the Tumor. J. Immunol. 161: 342-346 [Abstract] [Full Text]
Chen, B.-g., Shi, Y., Smith, J. D., Choi, D., Geiger, J. D., Mule, J. J. (1998). The Role of Tumor Necrosis Factor alpha �in Modulating the Quantity of Peripheral Blood-Derived, Cytokine-Driven Human Dendritic Cells and Its Role in Enhancing the Quality of Dendritic Cell Function in Presenting Soluble Antigens to CD4+ T Cells In Vitro. Blood 91: 4652-4661 [Abstract] [Full Text]
Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jeddi-Tehrani, M., Ruden, U., Lefvert, A.-K., Holm, G., Mellstedt, H. (1998). Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex-Restricted, CD8- and CD4-Specific T-Cell Responses. Blood 91: 2459-2466 [Abstract] [Full Text]
Shields, M. J., Assefi, N., Hodgson, W., Kim, E. J., Ribaudo, R. K. (1998). Characterization of the Interactions Between MHC Class I Subunits: A Systematic Approach for the Engineering of Higher Affinity Variants of {beta}2-Microglobulin. J. Immunol. 160: 2297-2307 [Abstract] [Full Text]
Dietz, A. B., Vuk-Pavlovic, S. (1998). High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells. Blood 91: 392-398 [Abstract] [Full Text]
Nagoshi, M., Goedegebuure, P. S., Burger, U. L., Sadanaga, N., Chang, M. P., Eberlein, T. J. (1998). Successful Adoptive Cellular Immunotherapy Is Dependent on Induction of a Host Immune Response Triggered by Cytokine (IFN-{gamma} and Granulocyte/Macrophage Colony-Stimulating Factor) Producing Donor Tumor-Infiltrating Lymphocytes. J. Immunol. 160: 334-344 [Abstract] [Full Text]
Hart, D. N.J. (1997). Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response. Blood 90: 3245-3287 [Full Text]